Trial intelligence / Profile preview

Minimum effect-site concentration of propofol to prevent responses to cranial reflex stimuli

2008-001037-98Phase 4Completed

Sponsor
Policlinico Gemelli
Start
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of propofol, sponsored by Policlinico Gemelli. Primary endpoint: Minimum effect-site concentration of propofol preventing responses to cranial reflex stimuli. Started Jun 2008; status: completed.

02

Drugs

propofol

Beyond the preview

Go deeper on 2008-001037-98.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001037-98.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call